WO2022055034A1 - Functional cosmetic composition using nordenau water - Google Patents
Functional cosmetic composition using nordenau water Download PDFInfo
- Publication number
- WO2022055034A1 WO2022055034A1 PCT/KR2020/017019 KR2020017019W WO2022055034A1 WO 2022055034 A1 WO2022055034 A1 WO 2022055034A1 KR 2020017019 W KR2020017019 W KR 2020017019W WO 2022055034 A1 WO2022055034 A1 WO 2022055034A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cosmetic composition
- extract
- water
- functional cosmetic
- composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 65
- 239000002537 cosmetic Substances 0.000 title claims abstract description 55
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 210000000130 stem cell Anatomy 0.000 claims abstract description 31
- 230000000694 effects Effects 0.000 claims abstract description 30
- 229940059958 centella asiatica extract Drugs 0.000 claims abstract description 20
- 230000002087 whitening effect Effects 0.000 claims abstract description 13
- 239000008213 purified water Substances 0.000 claims abstract description 10
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 6
- 239000011707 mineral Substances 0.000 claims abstract description 6
- 238000000034 method Methods 0.000 claims description 18
- 238000004113 cell culture Methods 0.000 claims description 16
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 claims description 8
- 239000003708 ampul Substances 0.000 claims description 8
- 239000003963 antioxidant agent Substances 0.000 claims description 8
- 235000006708 antioxidants Nutrition 0.000 claims description 8
- 239000006071 cream Substances 0.000 claims description 8
- 239000006210 lotion Substances 0.000 claims description 8
- 244000146462 Centella asiatica Species 0.000 claims description 7
- 235000004032 Centella asiatica Nutrition 0.000 claims description 7
- 239000004615 ingredient Substances 0.000 claims description 6
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 5
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 claims description 4
- 229960000458 allantoin Drugs 0.000 claims description 4
- 235000005152 nicotinamide Nutrition 0.000 claims description 4
- 239000011570 nicotinamide Substances 0.000 claims description 4
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 claims description 4
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 claims description 3
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 claims description 3
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 claims description 3
- 238000012258 culturing Methods 0.000 claims description 3
- 239000000686 essence Substances 0.000 claims description 3
- 239000000499 gel Substances 0.000 claims description 3
- 239000002105 nanoparticle Substances 0.000 claims description 3
- 229960003966 nicotinamide Drugs 0.000 claims description 3
- 239000000344 soap Substances 0.000 claims description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims description 2
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims description 2
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 claims description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 claims description 2
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims description 2
- 235000010323 ascorbic acid Nutrition 0.000 claims description 2
- 239000011668 ascorbic acid Substances 0.000 claims description 2
- 229960005070 ascorbic acid Drugs 0.000 claims description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 claims description 2
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims description 2
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims description 2
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 2
- 229920002674 hyaluronan Polymers 0.000 claims description 2
- 229960003160 hyaluronic acid Drugs 0.000 claims description 2
- RWPGFSMJFRPDDP-UHFFFAOYSA-L potassium metabisulfite Chemical compound [K+].[K+].[O-]S(=O)S([O-])(=O)=O RWPGFSMJFRPDDP-UHFFFAOYSA-L 0.000 claims description 2
- 229940043349 potassium metabisulfite Drugs 0.000 claims description 2
- 235000010263 potassium metabisulphite Nutrition 0.000 claims description 2
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 claims description 2
- 235000019252 potassium sulphite Nutrition 0.000 claims description 2
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims description 2
- 229940079827 sodium hydrogen sulfite Drugs 0.000 claims description 2
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims description 2
- 229940001584 sodium metabisulfite Drugs 0.000 claims description 2
- 235000010262 sodium metabisulphite Nutrition 0.000 claims description 2
- 229940001482 sodium sulfite Drugs 0.000 claims description 2
- 235000010265 sodium sulphite Nutrition 0.000 claims description 2
- 235000010384 tocopherol Nutrition 0.000 claims description 2
- 229960001295 tocopherol Drugs 0.000 claims description 2
- 239000011732 tocopherol Substances 0.000 claims description 2
- 229930003799 tocopherol Natural products 0.000 claims description 2
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 2
- DJEHXEMURTVAOE-UHFFFAOYSA-M potassium bisulfite Chemical compound [K+].OS([O-])=O DJEHXEMURTVAOE-UHFFFAOYSA-M 0.000 claims 1
- 235000010259 potassium hydrogen sulphite Nutrition 0.000 claims 1
- 210000004027 cell Anatomy 0.000 abstract description 14
- 230000003078 antioxidant effect Effects 0.000 abstract description 9
- 239000001963 growth medium Substances 0.000 abstract description 6
- 230000008929 regeneration Effects 0.000 abstract description 6
- 238000011069 regeneration method Methods 0.000 abstract description 6
- 239000004480 active ingredient Substances 0.000 abstract description 5
- 230000003712 anti-aging effect Effects 0.000 abstract description 4
- 230000001153 anti-wrinkle effect Effects 0.000 abstract description 4
- 230000007774 longterm Effects 0.000 abstract description 2
- 239000005445 natural material Substances 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 24
- -1 ascorbic acid-2-phosphate sodium salt Chemical class 0.000 description 12
- 230000006872 improvement Effects 0.000 description 12
- 108010035532 Collagen Proteins 0.000 description 11
- 102000008186 Collagen Human genes 0.000 description 11
- 229920001436 collagen Polymers 0.000 description 11
- 230000037303 wrinkles Effects 0.000 description 10
- 238000009472 formulation Methods 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 238000002360 preparation method Methods 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 210000000577 adipose tissue Anatomy 0.000 description 7
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 230000002401 inhibitory effect Effects 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- 239000002904 solvent Substances 0.000 description 6
- 229940088594 vitamin Drugs 0.000 description 6
- 229930003231 vitamin Natural products 0.000 description 6
- 235000013343 vitamin Nutrition 0.000 description 6
- 239000011782 vitamin Substances 0.000 description 6
- 150000003722 vitamin derivatives Chemical class 0.000 description 6
- 210000001789 adipocyte Anatomy 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 102000003425 Tyrosinase Human genes 0.000 description 4
- 108060008724 Tyrosinase Proteins 0.000 description 4
- 230000001976 improved effect Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 229930014626 natural product Natural products 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 230000036560 skin regeneration Effects 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- VBEQCZHXXJYVRD-GACYYNSASA-N uroanthelone Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CS)C(=O)N[C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)C(C)C)[C@@H](C)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)CNC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)CNC(=O)[C@H]1N(CCC1)C(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C1=CC=C(O)C=C1 VBEQCZHXXJYVRD-GACYYNSASA-N 0.000 description 4
- 102000009024 Epidermal Growth Factor Human genes 0.000 description 3
- 101800003838 Epidermal growth factor Proteins 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 239000004909 Moisturizer Substances 0.000 description 3
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 3
- 230000004663 cell proliferation Effects 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 229940116977 epidermal growth factor Drugs 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 210000002950 fibroblast Anatomy 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 230000036564 melanin content Effects 0.000 description 3
- 230000008099 melanin synthesis Effects 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000001333 moisturizer Effects 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 230000019612 pigmentation Effects 0.000 description 3
- 230000009759 skin aging Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- WHNFPRLDDSXQCL-UAZQEYIDSA-N α-msh Chemical compound C([C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC=1NC=NC=1)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)NCC(=O)N[C@@H](CCCCN)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](C(C)C)C(N)=O)NC(=O)[C@H](CO)NC(C)=O)C1=CC=C(O)C=C1 WHNFPRLDDSXQCL-UAZQEYIDSA-N 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- 229940015975 1,2-hexanediol Drugs 0.000 description 2
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 2
- VOUAQYXWVJDEQY-QENPJCQMSA-N 33017-11-7 Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)NCC(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N1[C@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O)CCC1 VOUAQYXWVJDEQY-QENPJCQMSA-N 0.000 description 2
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 2
- 108010075254 C-Peptide Proteins 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 102000018233 Fibroblast Growth Factor Human genes 0.000 description 2
- 108050007372 Fibroblast Growth Factor Proteins 0.000 description 2
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 description 2
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 description 2
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 2
- 102000014429 Insulin-like growth factor Human genes 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 108010050808 Procollagen Proteins 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 description 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 description 2
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000000440 bentonite Substances 0.000 description 2
- 229910000278 bentonite Inorganic materials 0.000 description 2
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 2
- 210000001185 bone marrow Anatomy 0.000 description 2
- 238000010609 cell counting kit-8 assay Methods 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000003636 conditioned culture medium Substances 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 230000002500 effect on skin Effects 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 210000004700 fetal blood Anatomy 0.000 description 2
- 239000012091 fetal bovine serum Substances 0.000 description 2
- 229940126864 fibroblast growth factor Drugs 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 2
- 239000003102 growth factor Substances 0.000 description 2
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 229940100573 methylpropanediol Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- 230000002335 preservative effect Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- 238000003809 water extraction Methods 0.000 description 2
- 239000001993 wax Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 1
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 1
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical class CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 1
- OWPUOLBODXJOKH-UHFFFAOYSA-N 2,3-dihydroxypropyl prop-2-enoate Chemical compound OCC(O)COC(=O)C=C OWPUOLBODXJOKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 240000003291 Armoracia rusticana Species 0.000 description 1
- 235000011330 Armoracia rusticana Nutrition 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- BYMMIQCVDHHYGG-UHFFFAOYSA-N Cl.OP(O)(O)=O Chemical compound Cl.OP(O)(O)=O BYMMIQCVDHHYGG-UHFFFAOYSA-N 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 102000004127 Cytokines Human genes 0.000 description 1
- 108090000695 Cytokines Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- QXNVGIXVLWOKEQ-UHFFFAOYSA-N Disodium Chemical compound [Na][Na] QXNVGIXVLWOKEQ-UHFFFAOYSA-N 0.000 description 1
- 238000002965 ELISA Methods 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 108010041308 Endothelial Growth Factors Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000016359 Fibronectins Human genes 0.000 description 1
- 108010067306 Fibronectins Proteins 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 101800001751 Melanocyte-stimulating hormone alpha Proteins 0.000 description 1
- 244000062730 Melissa officinalis Species 0.000 description 1
- 235000010654 Melissa officinalis Nutrition 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- ATGQXSBKTQANOH-UWVGARPKSA-N N-oleoylphytosphingosine Chemical compound CCCCCCCCCCCCCC[C@@H](O)[C@@H](O)[C@H](CO)NC(=O)CCCCCCC\C=C/CCCCCCCC ATGQXSBKTQANOH-UWVGARPKSA-N 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 102100027467 Pro-opiomelanocortin Human genes 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 241000923606 Schistes Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 101710147108 Tyrosinase inhibitor Proteins 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003756 Vitamin B7 Natural products 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 210000004504 adult stem cell Anatomy 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 150000005827 chlorofluoro hydrocarbons Chemical class 0.000 description 1
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 238000012790 confirmation Methods 0.000 description 1
- 239000008406 cosmetic ingredient Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000550 effect on aging Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 235000019439 ethyl acetate Nutrition 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 238000007443 liposuction Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- CQDGTJPVBWZJAZ-UHFFFAOYSA-N monoethyl carbonate Chemical compound CCOC(O)=O CQDGTJPVBWZJAZ-UHFFFAOYSA-N 0.000 description 1
- IJDNQMDRQITEOD-UHFFFAOYSA-N n-butane Chemical compound CCCC IJDNQMDRQITEOD-UHFFFAOYSA-N 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000005416 organic matter Substances 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 210000005259 peripheral blood Anatomy 0.000 description 1
- 239000011886 peripheral blood Substances 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 238000000053 physical method Methods 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 239000003380 propellant Substances 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 239000012679 serum free medium Substances 0.000 description 1
- 230000037384 skin absorption Effects 0.000 description 1
- 231100000274 skin absorption Toxicity 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- PPASLZSBLFJQEF-RXSVEWSESA-M sodium-L-ascorbate Chemical class [Na+].OC[C@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RXSVEWSESA-M 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- ZUFONQSOSYEWCN-UHFFFAOYSA-M sodium;2-(methylamino)acetate Chemical compound [Na+].CNCC([O-])=O ZUFONQSOSYEWCN-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000000516 sunscreening agent Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229940104261 taurate Drugs 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 238000011426 transformation method Methods 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229960000281 trometamol Drugs 0.000 description 1
- 238000002137 ultrasound extraction Methods 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000011912 vitamin B7 Nutrition 0.000 description 1
- 239000011735 vitamin B7 Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 230000037314 wound repair Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/965—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of inanimate origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/494—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
- A61K8/4946—Imidazoles or their condensed derivatives, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/673—Vitamin B group
- A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/981—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of mammals or bird
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/41—Particular ingredients further characterized by their size
- A61K2800/413—Nanosized, i.e. having sizes below 100 nm
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Definitions
- the present invention relates to a functional cosmetic composition using Nordenau water, and more particularly, to a functional cosmetic composition having a wrinkle improvement or whitening effect, comprising Nordenau water, human stem cell culture extract, Centella asiatica extract and purified water.
- the skin As the largest organ in the body, the skin is always in direct contact with the external environment and acts as a protective film to protect the living body from various stimuli or dry environments.
- Various physical factors, external environmental factors, infections, etc. bring about skin changes such as skin aging, skin contamination, dryness, troubles, and pigmentation.
- It is an object of the present invention to provide a functional cosmetic composition comprising a natural product having an excellent effect on wrinkle improvement or skin whitening as an active ingredient.
- the present invention provides a functional cosmetic composition comprising Nordenau water, human stem cell culture extract, Centella asiatica extract and purified water.
- the cosmetic composition according to the present invention contains, as active ingredients, natural products such as Nordenau water, which is rich in minerals and has excellent antioxidant effects, human stem cell culture extract and Centella asiatica extract, which are excellent in cell regeneration and anti-aging effects, as active ingredients. It is safe with few side effects, and it can exhibit improved wrinkle improvement or whitening effect.
- 1 is a graph showing the cell proliferation effect according to an experimental example of the present invention.
- FIG. 2 is a graph showing the collagen synthesis effect according to an experimental example of the present invention.
- 3 and 4 are graphs showing the effect of inhibiting melanin synthesis and tyrosinase enzyme activity according to an experimental example of the present invention.
- the present invention provides a functional cosmetic composition comprising Nordenau water, human stem cell culture extract, Centella asiatica extract and purified water.
- Nordenau water is mineral water flowing from the basement of the Nordenau Schist (Tomes Cave), about 200 km away from Frankfurt, Germany. It is a story that various diseases were cured by drinking this water. It is known as a miracle water and one of the world's four most famous waters. Nordenau water is rich in minerals (calcium, potassium, magnesium) and has excellent ability to remove active oxygen.
- human-derived stem cells refers to stem cells obtained from adults other than embryonic stem cells, and for example, adipose tissue, bone marrow, umbilical cord blood, and peripheral blood, including blood and tissue basal. Includes all stem cells originating from
- the human-derived stem cell culture solution extract is a human adipocyte conditioned media extract, specifically, the culture medium obtained by culturing human-derived adipose stem cells and the cultured adipose stem cells are disrupted. It may include an extract obtained by
- the culture solution extract promotes the proliferation of fibroblasts that synthesize collagen and induces vascular endothelial growth factor (VEGF), which induces the secretion of new blood vessels and other regeneration promoting factors, induces cell activity and makes skin color.
- VEGF vascular endothelial growth factor
- Hepatocyte growth factor (HGF) that promotes division
- IGF insulin-like growth factor
- EGF epidermal growth factor
- FGF fibroblast growth factor
- FGF fibroblast growth factor
- the culture medium extract can have a long-term skin improvement effect by inducing cell division when absorbed into the skin, and has an effect on aging through cell regeneration or restoration.
- adipose stem cells are easier to collect than bone marrow stem cells or umbilical cord blood stem cells, and have the advantage of being able to mass-cultivate and contain a large amount of stem cells.
- Centella asiatica is a dicotyledonous plant commonly found in the mountains or fields of the southern island of the Korean Peninsula. Because of the medecassic component in the leaves and stems of Centella asiatica, it is effective in wound healing, especially in skin regeneration, anti-wrinkle, blood circulation, anti-inflammatory, soothing, anti-aging due to antioxidant action, elasticity improvement, and prevention of pigmentation. etc. are also effective.
- the Centella asiatica extract may be extracted with water, C1 to C4 alcohol or a mixed solvent thereof, and may preferably be a hot water extract, but is not limited thereto.
- Centella asiatica extract may be obtained by extracting the roots, stems, leaves, flowers, fruits, or a mixture of these parts of Centella asiatica, and the Centella asiatica may be collected or cultivated in nature, or purchased commercially.
- extract refers to a substance obtained by extracting a component of a natural product regardless of an extraction method, an extraction solvent, an extracted component, or the form of an extract. It may include any material obtainable by processing or processing by the method.
- the extract may be extracted according to a method commonly used in the art, for example, hot water extraction method, ultrasonic extraction method, filtration method, reflux extraction method, etc., these are performed alone or in combination of two or more methods.
- a method commonly used in the art for example, hot water extraction method, ultrasonic extraction method, filtration method, reflux extraction method, etc., these are performed alone or in combination of two or more methods.
- purified water refers to water made by distilling water or filtration through chemical and physical methods, and is clean water free of solid particles, microorganisms, organic matter, fusion ions, etc. contained in water. do. As a major component of cosmetics, it is used to prevent discoloration, deterioration, and contamination of cosmetics.
- the composition may include 20 to 40% by weight of Nordenau water, 15 to 30% by weight of human stem cell culture extract, 0.005 to 0.1% by weight of Centella asiatica extract, and the remaining amount of purified water.
- composition may further include one or more components selected from the group consisting of allantoin, hyaluronic acid, niacinamide, acetylhexapeptide-8, and extract of horseradish.
- the composition may be provided to the skin in the form of nanoparticles with an average diameter of 0.1 to 100 nm, but is not limited thereto.
- composition By providing the composition as nano-sized particles, it is possible to more easily pass through the skin cell gap, thereby increasing the skin absorption rate of the composition.
- cosmetics may include functional cosmetics having an effect of preventing or improving skin aging, etc., and the functional cosmetics have specialized functionalities that emphasize physiologically active efficacy and effects, unlike general cosmetics. , refers to cosmetics emphasizing specific efficacy and effects, such as skin wrinkle improvement and whitening, as defined in the Cosmetics Act.
- the composition may have a wrinkle improvement effect.
- wrinkle improvement means suppressing or inhibiting the generation of wrinkles on the skin, or alleviating the already generated wrinkles.
- the anti-wrinkle effect may include a conventional skin protection effect such as preventing or improving skin wrinkles, inhibiting or improving skin aging.
- a conventional skin protection effect such as preventing or improving skin wrinkles, inhibiting or improving skin aging.
- collagen is involved in the mechanical strength of the skin, the bonding strength and elasticity of tissues, etc.
- effects such as improvement of skin elasticity, skin regeneration, wound healing, and repair and regeneration of damaged skin tissue can be obtained by the composition.
- the composition may have a whitening effect.
- whitening refers to an action of improving skin troubles by inhibiting, inhibiting, or alleviating excessive deposition of melanin pigment and the like, thereby preventing skin blackening caused by the pigmentation.
- the cosmetic composition according to the present invention may further include one or more of the ingredients listed in the list of cosmetic raw materials registered with the Ministry of Food and Drug Safety and ICID (International Cosmetic Ingredients).
- the cosmetic composition may include an organic solvent, a solubilizer, a thickener, a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a fragrance, a surfactant, an emulsifier, a filler, a sequestering agent, a preservative, a vitamin, a blocking agent, It may further comprise one or more adjuvants commonly used in the cosmetic field, such as wetting agents, dyes and pigments, hydrophilic or lipophilic actives, or any other ingredients commonly used in cosmetics.
- the antioxidant prevents oxidation of oily components of cosmetics to maintain the quality, preservation, and safety of cosmetics
- tocopherol, sodium sulfite, sodium hydrogen sulfite, sodium metabisulfite, potassium sulfite, potassium hydride Rovertfite, potassium metabisulfite, butylated hydroxytoluene, butylhydroxyanisole, ascorbic acid, ascorbyl palmitate, etc. may include, but are not limited to, various types known in the art. Antioxidants may be used.
- the vitamin may include a water-soluble or oil-soluble vitamin, and the water-soluble vitamin is a water-soluble vitamin that can be formulated in cosmetics, preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine hydrochloride, vitamin B12, pantothenic acid, nicotinic acid, and nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like, and more preferably vitamin C, which helps collagen synthesis.
- a water-soluble or oil-soluble vitamin is a water-soluble vitamin that can be formulated in cosmetics, preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine hydrochloride, vitamin B12, pantothenic acid, nicotinic acid, and nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like, and more preferably vitamin C, which helps collagen synthesis.
- salts thereof thiamine hydrochloride, sodium ascorbate salt, etc.
- derivatives ascorbic acid-2-phosphate sodium salt, ascorbic acid-2-phosphate magnesium salt, etc.
- the water-soluble vitamin is a microorganism transformation method , can be obtained by a conventional method such as a purification method from a culture of a microorganism, an enzymatic method or a chemical synthesis method.
- the cosmetic composition according to the present invention may be prepared in any formulation conventionally prepared in the technical field to which the present invention pertains.
- any formulation conventionally prepared in the technical field to which the present invention pertains For example, to be formulated into lotions, emulsions, skins, lotions, essences, ampoules, creams, pastes, gels, solutions, suspensions, oils, waxes, packs, powders, foundations, sprays, surfactant-containing cleansing, soaps, etc.
- the present invention is not limited thereto.
- the cosmetic composition according to the present invention is a cream or gel formulation
- animal oil, vegetable oil, wax, paraffin, starch, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be further included as a carrier component.
- the cosmetic composition is a solution or emulsion formulation
- a solvent, solvating agent or emulsifying agent water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, propylene glycol, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid It may further include esters and the like.
- the cosmetic composition is a suspension formulation
- a liquid diluent such as water, ethanol or propylene glycol
- a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be further included.
- lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be further included as a carrier component, and in particular, in the case of a spray formulation, additional chlorofluorohydrocarbon , may further include a propellant such as propane/butane or dimethyl ether.
- the cosmetic composition is a surfactant-containing cleansing formulation
- Ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glycerides, fatty acid diethanolamide, vegetable oil, linoline derivatives or ethoxylated glycerol fatty acid esters may be further included.
- the cosmetic composition according to the present invention may be applied alone or in overlapping use, or may be used by overlapping application with other cosmetic compositions other than the present invention.
- the cosmetic composition according to the present invention can be used according to a conventional method of use, and the number of times of use can be varied according to the skin condition or taste of the user.
- Nordenau water a German medical mineral water, was prepared, and human adipose-derived mesenchymal stem cells-conditioned medium (ADSC-CM) extract and Centella asiatica extract were prepared.
- ADSC-CM human adipose-derived mesenchymal stem cells-conditioned medium
- Adipose stem cells are separated from adipose tissue obtained through liposuction, suspended in a substrate medium, inoculated in a culture vessel, and cultured in an incubator at 37° C., CO 2 for 24 hours, then the substrate medium is removed and a differentiation medium is added 3 After culturing for one day, adipocyte media was added and the cells were differentiated into adipocytes.
- the culture solution obtained in this process was separated and purified and used as an extract of the adipose tissue-derived stem cell culture solution of the present invention.
- Centella asiatica was collected, washed, dried, and then pulverized. 100 g of pulverized Centella asiatica was added to 2 L of distilled water and heated at about 95° C. for 3 hours, followed by hot water extraction. After filtration, the resultant was concentrated under reduced pressure at 40° C. or lower, and then freeze-dried.
- a cosmetic composition (Example 1) containing Nordenau water, human adipose tissue-derived stem cell culture extract, and Centella asiatica extract prepared according to the above was prepared with the components and contents of Table 1.
- Human dermal fibroblast (HDF) cells which are human dermal fibroblasts purchased from ATCC, were aliquoted at 5 ⁇ 10 3 cells/well in a 96 well plate, and 0.5% FBS (fetal bovine serum) was added at 37° C., 5% CO 2 . It was cultured for 24 hours in DMEM (Invitrogen-Gibco-BRL, Grand Island, NY) medium. In Example 1 and Comparative Example diluted with a culture medium to a final concentration of 1% (v/v), 50 ⁇ g/ml of an epidermal growth factor (EGF) sample was added and cultured for 24 hours. 10 ⁇ l of CCK-8 (Cell counting kit-8, Dojindo, Gaithersburg, MD, USA) solution was added to each well and incubated for 2 hours. The absorbance was measured at 450 nm using a microplate reader.
- FBS fetal bovine serum
- Example 1 exhibited a more improved cell proliferation effect than the growth factor EGF.
- HDF cells were aliquoted in a 96-well plate at 5 ⁇ 10 3 cells/well, cultured in DMEM medium at 37° C. for 24 hours, and then treated with a cosmetic composition of another company and Example 1 according to the present invention at 50 ⁇ g/ml. Further incubation in serum-free medium for the next 48 hours. After incubation, the amount of collagen synthesis was measured by collecting the supernatant of each well and measuring the amount of procollagen type I C-peptide (PICP) using a kit (Takara, JAPAN).
- PICP procollagen type I C-peptide
- Example 1 had a higher collagen synthesis amount than that of other stem cell cultures.
- Melanin content was measured by dispensing B16F10 melanoma cells distributed from ATCC at 2 ⁇ 10 4 cells/well in a 24-well plate, and cultured at 37° C., 5% CO 2 for 18 hours, and then the culture medium was removed.
- the culture medium containing 0.2 ppm ⁇ -MSH ⁇ -melanocyte stimulating hormone, Sigma-Aldrich
- each sample was added by concentration and cultured for 24 hours.
- the cells are recovered by treatment with trypsin-EDTA, and the melanin content in the cells is measured by ELISA for absorbance at 405 nm. was measured.
- Example 1 when Example 1 was treated, melanin production and tyrosinase enzyme activity were significantly inhibited as the concentration increased compared to the case of ⁇ -MSH alone treatment.
- Example 1 when the concentration of Example 1 is 50 ⁇ g / ml, it is shown that the inhibitory effect of melanin and tyrosinase enzyme activity is superior to that of arbutin, a positive control known as a conventional tyrosinase inhibitor.
- Table 2 shows the ingredients and contents of functional ampoules containing Nordenau water, human adipose tissue-derived stem cell culture extract, and Centella asiatica extract as active ingredients according to an embodiment of the present invention.
- a functional ampoule was prepared using the nano-size particle manufacturing method.
Abstract
The present invention relates to a functional cosmetic composition using Nordenau water. Specifically, the present invention provides a functional cosmetic composition which has an anti-wrinkle or whitening effect, and comprises: Nordenau water; a human stem cell-derived culture medium extract; a Centella asiatica extract; and purified water. The cosmetic composition contains, as active ingredients, natural substances such as: Nordenau water, which is rich in minerals and has excellent antioxidant effects; a human stem cell-derived culture extract, which has excellent effects on cell regeneration and anti-aging; and a Centella asiatica extract, and thus is safe and has few side effects even after long-term use, and can exhibit an even more enhanced anti-wrinkle or whitening effect.
Description
본 발명은 노르데나우수를 이용한 기능성 화장료 조성물에 관한 것으로, 상세하게는 노르데나우수, 인체유래 줄기세포 배양액 추출물, 병풀 추출물 및 정제수를 포함하는 주름개선 또는 미백 효과를 갖는 기능성 화장료 조성물에 관한 것이다.The present invention relates to a functional cosmetic composition using Nordenau water, and more particularly, to a functional cosmetic composition having a wrinkle improvement or whitening effect, comprising Nordenau water, human stem cell culture extract, Centella asiatica extract and purified water.
피부는 신체 중 가장 큰 기관으로 항상 외부 환경과 직접 접하고 있으면서 여러 가지 자극이나 건조한 환경으로부터 생체를 보호하는 보호막의 역할을 하고 있으며, 다른 기관에 비하여 새로운 세포의 생성과 소멸이 활발히 일어나는 기관이다. 여러 가지 물리적 요인, 외부 환경적 요인, 감염 등은 피부 노화, 피부 오염, 건조, 트러블, 색소 침착 등의 피부 변화를 가져온다.As the largest organ in the body, the skin is always in direct contact with the external environment and acts as a protective film to protect the living body from various stimuli or dry environments. Various physical factors, external environmental factors, infections, etc. bring about skin changes such as skin aging, skin contamination, dryness, troubles, and pigmentation.
현대인들의 삶의 질이 향상되고 이에 따른 사람들의 외모에 대한 관심이 증가하면서 화장품의 수요가 급증하였고, 그 중에서도 피부 노화, 주름 개선, 미백 등의 효능이 뛰어난 기능성 화장품들에 대한 관심이 더욱 집중되고 있다.As the quality of life of modern people has improved and people's interest in their appearance has increased, the demand for cosmetics has surged. there is.
또한, 최근에는 기존 화학물질들의 독성, 저활성, 용도의 한계성, 과량복용에 따른 부작용 등의 여러 가지 문제로 인해 부작용 가능성이 적은 소재를 개발하려는 일환으로 천연물로부터 얻어진 주름 완화, 미백 등의 기능을 가진 기능성 화장품의 연구 개발이 활발히 진행 중이다. 자연친화적인 천연 재료는 안전하고 피부에 부작용이 적어, 천연 재료를 이용한 화장품에 대한 소비자들의 호응이 높아짐에 따라 기능성 화장료 조성물의 원료로서 개발 가치가 한층 늘어나고 있는 실정이다.In addition, in recent years, as part of the development of materials with less possibility of side effects due to various problems such as toxicity, low activity, limitation of use, and side effects due to overdose of existing chemicals, functions such as wrinkle relief and whitening obtained from natural products have been improved. Research and development of functional cosmetics with Nature-friendly natural materials are safe and have few side effects on the skin, and as consumers' response to cosmetics using natural materials increases, the development value as a raw material for functional cosmetic compositions is further increasing.
본 발명의 목적은 주름 개선 또는 피부 미백에 우수한 효과를 가진 천연물을 유효성분으로 포함하는 기능성 화장료 조성물을 제공하는 데에 있다.It is an object of the present invention to provide a functional cosmetic composition comprising a natural product having an excellent effect on wrinkle improvement or skin whitening as an active ingredient.
상기의 목적을 해결하기 위하여, 본 발명은 노르데나우수, 인체유래 줄기세포 배양액 추출물, 병풀 추출물 및 정제수를 포함하는 기능성 화장료 조성물을 제공한다.In order to solve the above object, the present invention provides a functional cosmetic composition comprising Nordenau water, human stem cell culture extract, Centella asiatica extract and purified water.
본 발명에 따른 화장료 조성물은 미네랄이 풍부하고 항산화 효과가 우수한 노르데나우수, 세포 재생, 노화 방지 효과 등이 우수한 인체유래 줄기세포 배양액 추출물, 병풀 추출물 등의 천연물을 유효성분으로 함유함으로써, 장시간 사용에도 부작용이 적고 안전하며, 보다 향상된 주름개선 또는 미백 효과를 나타낼 수 있다.The cosmetic composition according to the present invention contains, as active ingredients, natural products such as Nordenau water, which is rich in minerals and has excellent antioxidant effects, human stem cell culture extract and Centella asiatica extract, which are excellent in cell regeneration and anti-aging effects, as active ingredients. It is safe with few side effects, and it can exhibit improved wrinkle improvement or whitening effect.
도 1은 본 발명의 일 실험예에 따른 세포 증식 효과를 나타낸 그래프이다.1 is a graph showing the cell proliferation effect according to an experimental example of the present invention.
도 2는 본 발명의 일 실험예에 따른 콜라겐 합성 효과를 나타낸 그래프이다.2 is a graph showing the collagen synthesis effect according to an experimental example of the present invention.
도 3 및 도 4는 본 발명의 일 실험예에 따른 멜라닌 합성 저해 및 티로시나제 효소 활성 저해 효과를 나타낸 그래프이다.3 and 4 are graphs showing the effect of inhibiting melanin synthesis and tyrosinase enzyme activity according to an experimental example of the present invention.
도 5는 본 발명의 일 실험예에 따른 미백 개선 효과를 나타낸 그래프이다.5 is a graph showing the whitening improvement effect according to an experimental example of the present invention.
이하, 본 발명을 상세하게 설명하기로 한다.Hereinafter, the present invention will be described in detail.
본 발명은 노르데나우수, 인체유래 줄기세포 배양액 추출물, 병풀 추출물 및 정제수를 포함하는 기능성 화장료 조성물을 제공한다.The present invention provides a functional cosmetic composition comprising Nordenau water, human stem cell culture extract, Centella asiatica extract and purified water.
본 명세서에서, "노르데나우수(Nordenau water)"란, 독일 프랑크푸르트에서 약 200km 떨어져 있는 노르데나우 편암 동굴(토메스 동굴) 지하에서 흘러나오는 미네랄워터로, 이 물을 마셔 다양한 질병이 치유되었다는 이야기들이 전해지면서 기적의 물이자 세계 4대 명수로 알려져 있다. 노르데나우수는 미네랄(칼슘, 칼륨, 마그네슘) 등이 풍부하고 활성산소 제거능력이 탁월하다.As used herein, "Nordenau water" is mineral water flowing from the basement of the Nordenau Schist (Tomes Cave), about 200 km away from Frankfurt, Germany. It is a story that various diseases were cured by drinking this water. It is known as a miracle water and one of the world's four most famous waters. Nordenau water is rich in minerals (calcium, potassium, magnesium) and has excellent ability to remove active oxygen.
본 명세서에서, "인체유래 줄기세포"란, 배아줄기세포(embryonic stem cell)를 제외한 성체로부터 얻어지는 줄기세포를 의미하며, 예를 들면 지방, 골수, 제대혈 및 말초혈액을 포함하는 혈액 및 조직의 기저에서 기원되는 줄기세포를 모두 포함한다. As used herein, the term "human-derived stem cells" refers to stem cells obtained from adults other than embryonic stem cells, and for example, adipose tissue, bone marrow, umbilical cord blood, and peripheral blood, including blood and tissue basal. Includes all stem cells originating from
바람직하게는, 상기 인체유래 줄기세포 배양액 추출물은 인체유래 지방줄기세포 배양액 추출물(human adipocyte conditioned media extract)로, 상세하게는 인체유래 지방줄기세포를 배양하여 얻은 배양액 및 상기 배양한 지방줄기세포를 파쇄하여 얻은 추출물을 포함할 수 있다. Preferably, the human-derived stem cell culture solution extract is a human adipocyte conditioned media extract, specifically, the culture medium obtained by culturing human-derived adipose stem cells and the cultured adipose stem cells are disrupted. It may include an extract obtained by
상기 배양액 추출물은 콜라겐을 합성하는 섬유아세포의 증식을 촉진하고 새로운 혈관 및 기타 재생 촉진인자의 분비를 유도하는 혈관내피성장인자(vascular endothelial growth factor, VEGF), 세포활성을 유도하고 피부색을 만드는 세포의 분열을 촉진하는 간세포성장인자(hepatocyte growth factor, HGF), 세포 재생과 성장을 촉진하는 인슐린유사성장인자(insulin-like growth factor, IGF), 피부 조직의 재생 및 기능을 강화하는 내피세포성장인자(epidermal growth factor, EGF), 콜라겐의 합성을 유도하는 섬유아세포성장인자(fibroblast growth factor, FGF) 등 150여 가지의 성장인자(growth factor)를 포함할 수 있고, 콜라겐(collagen), 사이토카인(cytokine), 피브로넥틴(fibronectin) 등의 세포외기질 단백질을 다량 함유할 수 있다.The culture solution extract promotes the proliferation of fibroblasts that synthesize collagen and induces vascular endothelial growth factor (VEGF), which induces the secretion of new blood vessels and other regeneration promoting factors, induces cell activity and makes skin color. Hepatocyte growth factor (HGF) that promotes division, insulin-like growth factor (IGF) that promotes cell regeneration and growth, and endothelial growth factor that enhances skin tissue regeneration and function ( Epidermal growth factor, EGF, may include 150 kinds of growth factors such as fibroblast growth factor (FGF) that induces collagen synthesis, collagen, cytokine ), may contain a large amount of extracellular matrix proteins such as fibronectin.
상기 배양액 추출물은 피부에 흡수될 때 세포분열을 유도하여 장기간의 피부개선 효과를 가질 수 있으며, 세포 재생 또는 복원을 통해 노화 방지에도 효과를 가진다.The culture medium extract can have a long-term skin improvement effect by inducing cell division when absorbed into the skin, and has an effect on aging through cell regeneration or restoration.
또한, 지방줄기세포는 성체줄기세포의 한 종류로써 골수줄기세포나 제대혈 줄기세포보다 채취하기가 쉽고 대량배양이 가능하면서도 줄기세포 함유량이 많은 장점이 있다.In addition, as a type of adult stem cells, adipose stem cells are easier to collect than bone marrow stem cells or umbilical cord blood stem cells, and have the advantage of being able to mass-cultivate and contain a large amount of stem cells.
본 명세서에서, "병풀(Centella asiatica)"이란, 한반도 남부 섬의 산이나 들에 흔히 나는 쌍떡잎식물 이판화군 산형화목 미나리과의 여러해살이풀로, 시카(CICA)라고도 불린다. 병풀의 잎과 줄기에 있는 마데카식산(medecassic) 성분 때문에 상처 치유, 특히, 피부 재생에 효과적이며, 주름방지, 혈액순환, 소염, 진정작용, 항산화 작용으로 인한 노화방지, 탄력증진, 색소침착 방지 등에도 효과가 있다.As used herein, " Centella asiatica " is a dicotyledonous plant commonly found in the mountains or fields of the southern island of the Korean Peninsula. Because of the medecassic component in the leaves and stems of Centella asiatica, it is effective in wound healing, especially in skin regeneration, anti-wrinkle, blood circulation, anti-inflammatory, soothing, anti-aging due to antioxidant action, elasticity improvement, and prevention of pigmentation. etc. are also effective.
본 발명에 있어서, 상기 병풀 추출물은 물, C1 내지 C4 알코올 또는 이들의 혼합 용매로 추출된 것일 수 있으며, 바람직하게는 열수 추출물일 수 있으나, 이에 제한되는 것은 아니다.In the present invention, the Centella asiatica extract may be extracted with water, C1 to C4 alcohol or a mixed solvent thereof, and may preferably be a hot water extract, but is not limited thereto.
상기 병풀 추출물은 병풀의 뿌리, 줄기, 잎, 꽃, 열매 또는 이들 부위의 혼합물을 추출한 것일 수 있으며, 상기 병풀은 자연에서 채취 또는 재배된 것일 수 있고, 상업적으로 판매되는 것을 구입한 것일 수 있다.The Centella asiatica extract may be obtained by extracting the roots, stems, leaves, flowers, fruits, or a mixture of these parts of Centella asiatica, and the Centella asiatica may be collected or cultivated in nature, or purchased commercially.
본 명세서에서, "추출물"이란, 추출 방법, 추출 용매, 추출된 성분 또는 추출물의 형태를 불문하고 천연물의 성분을 뽑아냄으로써 얻어진 물질을 의미하는 것으로, 천연물의 성분을 뽑아내어 얻어진 물질을 추출 후 다른 방법으로 가공 또는 처리하여 얻어질 수 있는 물질을 모두 포함할 수 있다.As used herein, the term "extract" refers to a substance obtained by extracting a component of a natural product regardless of an extraction method, an extraction solvent, an extracted component, or the form of an extract. It may include any material obtainable by processing or processing by the method.
상기 추출물은 당해 기술 분야에서 통상적으로 사용하는 방법에 따라 추출될 수 있고, 예를 들어, 열수 추출법, 초음파 추출법, 여과법, 환류 추출법 등이 있으며, 이들은 단독으로 수행되거나 2종 이상의 방법을 병용하여 수행될 수 있다.The extract may be extracted according to a method commonly used in the art, for example, hot water extraction method, ultrasonic extraction method, filtration method, reflux extraction method, etc., these are performed alone or in combination of two or more methods. can be
본 명세서에서, "정제수(purified water)"란, 상수를 증류하거나 화학적, 물리적 방법을 통해 여과하여 만든 물로써, 물에 함유되어 있는 고체입자, 미생물, 유기물, 융해 이온 등이 없는 깨끗한 물을 의미한다. 화장품의 주요 요소로, 화장품의 변색, 변질, 오염 등을 막기 위해 사용된다.As used herein, "purified water" refers to water made by distilling water or filtration through chemical and physical methods, and is clean water free of solid particles, microorganisms, organic matter, fusion ions, etc. contained in water. do. As a major component of cosmetics, it is used to prevent discoloration, deterioration, and contamination of cosmetics.
본 발명에 있어서, 상기 조성물은 노르데나우수 20 내지 40 중량%, 인체유래 줄기세포 배양액 추출물 15 내지 30 중량%, 병풀 추출물 0.005 내지 0.1 중량% 및 잔량의 정제수를 포함할 수 있다.In the present invention, the composition may include 20 to 40% by weight of Nordenau water, 15 to 30% by weight of human stem cell culture extract, 0.005 to 0.1% by weight of Centella asiatica extract, and the remaining amount of purified water.
상기 조성물은 알란토인, 히알루론산, 나이아신아마이드, 아세틸헥사펩타이드-8, 및 마치현 추출물로 이루어진 군에서 선택된 하나 이상의 성분을 더 포함할 수 있다.The composition may further include one or more components selected from the group consisting of allantoin, hyaluronic acid, niacinamide, acetylhexapeptide-8, and extract of horseradish.
본 발명에 있어서, 상기 조성물은 평균직경 0.1 내지 100 nm 나노입자의 형태로 피부에 제공될 수 있으나, 이에 제한되는 것은 아니다.In the present invention, the composition may be provided to the skin in the form of nanoparticles with an average diameter of 0.1 to 100 nm, but is not limited thereto.
상기 조성물을 나노크기의 입자로 제공함으로써, 피부세포간극을 보다 용이하게 통과할 수 있고, 이에 따라 상기 조성물의 피부 흡수율을 증대시킬 수 있다.By providing the composition as nano-sized particles, it is possible to more easily pass through the skin cell gap, thereby increasing the skin absorption rate of the composition.
본 명세서에서, "화장료"란, 피부 노화 등의 예방 또는 개선의 효과를 가지는 기능성 화장료를 포함할 수 있고, 상기 기능성 화장료는 일반 화장료와 달리 생리활성적인 효능, 효과가 강조된 전문적인 기능성을 갖는 것으로, 화장품법에 정의된 바에 따라 피부 주름 개선, 미백 등 특정 효능과 효과가 강조된 화장료를 의미한다.In the present specification, the term "cosmetics" may include functional cosmetics having an effect of preventing or improving skin aging, etc., and the functional cosmetics have specialized functionalities that emphasize physiologically active efficacy and effects, unlike general cosmetics. , refers to cosmetics emphasizing specific efficacy and effects, such as skin wrinkle improvement and whitening, as defined in the Cosmetics Act.
본 발명에 있어서, 상기 조성물은 주름개선 효과를 가질 수 있다.In the present invention, the composition may have a wrinkle improvement effect.
본 명세서에서, "주름개선"이란, 피부에 주름이 생성되는 것을 억제 또는 저해하거나, 이미 생성된 주름을 완화시키는 것을 의미한다. As used herein, "wrinkle improvement" means suppressing or inhibiting the generation of wrinkles on the skin, or alleviating the already generated wrinkles.
상기 주름개선 효과는 피부의 주름 예방, 개선, 피부 노화 억제 또는 개선 등 통상적인 피부 보호 효과를 포함할 수 있다. 또한, 콜라겐은 피부의 기계적 견고성, 조직의 결합력 및 탄력성 등에 관여하므로, 상기 조성물에 의해 피부 탄력 개선, 피부 재생, 상처 치유, 손상된 피부 조직의 수복 및 재생 등의 효과를 얻을 수 있다.The anti-wrinkle effect may include a conventional skin protection effect such as preventing or improving skin wrinkles, inhibiting or improving skin aging. In addition, since collagen is involved in the mechanical strength of the skin, the bonding strength and elasticity of tissues, etc., effects such as improvement of skin elasticity, skin regeneration, wound healing, and repair and regeneration of damaged skin tissue can be obtained by the composition.
본 발명에 있어서, 상기 조성물은 미백 효과를 가질 수 있다.In the present invention, the composition may have a whitening effect.
본 명세서에서, "미백"이란, 멜라닌 색소 등의 과다 침착을 억제, 저해, 또는 완화시켜, 상기 색소 침착으로 야기되는 피부의 흑화를 방지하여 피부 트러블을 개선하는 작용을 의미한다. As used herein, "whitening" refers to an action of improving skin troubles by inhibiting, inhibiting, or alleviating excessive deposition of melanin pigment and the like, thereby preventing skin blackening caused by the pigmentation.
본 발명에 따른 화장료 조성물은 식품의약품안전처에 등록된 화장품 원료 리스트 및 ICID(국제화장품 원료집)에 등재되어 있는 성분 중에서 1종 이상을 더 포함할 수 있다. 예를 들어, 상기 화장료 조성물은 유기 용매, 용해제, 농축제, 겔화제, 연화제, 산화방지제, 현탁화제, 안정화제, 방향제, 계면활성제, 유화제, 충전제, 금속이온 봉쇄제, 방부제, 비타민, 차단제, 습윤화제, 염료 및 안료, 친수성 또는 친유성 활성제, 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품 분야에서 통상적으로 사용되는 보조제를 하나 이상 더 포함할 수 있다.The cosmetic composition according to the present invention may further include one or more of the ingredients listed in the list of cosmetic raw materials registered with the Ministry of Food and Drug Safety and ICID (International Cosmetic Ingredients). For example, the cosmetic composition may include an organic solvent, a solubilizer, a thickener, a gelling agent, an emollient, an antioxidant, a suspending agent, a stabilizer, a fragrance, a surfactant, an emulsifier, a filler, a sequestering agent, a preservative, a vitamin, a blocking agent, It may further comprise one or more adjuvants commonly used in the cosmetic field, such as wetting agents, dyes and pigments, hydrophilic or lipophilic actives, or any other ingredients commonly used in cosmetics.
상기 산화방지제는 화장품의 유성성분의 산화를 방지하여 화장품의 품질, 보존, 및 안전성을 유지하는 것으로, 토코페롤, 소듐설파이트, 소듐하이드로젠설파이트, 소듐메타바이설파이트, 포타슘설파이트, 포타슘하이드로젠설파이트, 포타슘메타바이설파이트, 부틸레이티드하이드록시톨루엔, 부틸하이드록시아니솔, 아스코르브산, 아스코르빌팔미테이트 등을 포함할 수 있으나, 이에 제한되지 않고, 당해 기술분야에 공지된 다양한 산화방지제를 사용할 수 있다.The antioxidant prevents oxidation of oily components of cosmetics to maintain the quality, preservation, and safety of cosmetics, tocopherol, sodium sulfite, sodium hydrogen sulfite, sodium metabisulfite, potassium sulfite, potassium hydride Rosensulfite, potassium metabisulfite, butylated hydroxytoluene, butylhydroxyanisole, ascorbic acid, ascorbyl palmitate, etc. may include, but are not limited to, various types known in the art. Antioxidants may be used.
상기 비타민은 수용성 또는 유용성 비타민을 포함할 수 있고, 상기 수용성 비타민은 수용성 비타민으로서 화장품에 배합 가능한 것으로, 바람직하게는 비타민 B1, 비타민 B2, 비타민 B6, 피리독신, 염산피리독신, 비타민 B12, 판토텐산, 니코틴산, 니코틴산아미드, 엽산, 비타민C, 비타민 H 등을 들 수 있으며, 보다 바람직하게는 콜라겐 합성이 도움을 주는 비타민 C를 포함할 수 있다. 또한, 그들의 염 (티아민염산염, 아스코르빈산나트륨염 등)이나 유도체(아스코르빈산-2-인산나트륨염, 아스코르빈산-2-인산마그네슘염 등)도 포함될 수 있고, 상기 수용성 비타민은 미생물 변환법, 미생물의 배양물로부터의 정제법, 효소법 또는 화학 합성법 등의 통상의 방법에 의해 수득될 수 있다.The vitamin may include a water-soluble or oil-soluble vitamin, and the water-soluble vitamin is a water-soluble vitamin that can be formulated in cosmetics, preferably vitamin B1, vitamin B2, vitamin B6, pyridoxine, pyridoxine hydrochloride, vitamin B12, pantothenic acid, nicotinic acid, and nicotinic acid amide, folic acid, vitamin C, vitamin H, and the like, and more preferably vitamin C, which helps collagen synthesis. In addition, salts thereof (thiamine hydrochloride, sodium ascorbate salt, etc.) or derivatives (ascorbic acid-2-phosphate sodium salt, ascorbic acid-2-phosphate magnesium salt, etc.) may be included, and the water-soluble vitamin is a microorganism transformation method , can be obtained by a conventional method such as a purification method from a culture of a microorganism, an enzymatic method or a chemical synthesis method.
본 발명에 따른 화장료 조성물은 본 발명이 속하는 기술 분야에서 통상적으로 제조되는 어떠한 제형으로도 제조될 수 있다. 예를 들어, 화장수, 유액, 스킨, 로션, 에센스, 앰플, 크림, 페이스트, 젤, 용액, 현탁액, 오일, 왁스, 팩, 파우더, 파운데이션, 스프레이, 계면활성제-함유 클렌징, 비누 등으로 제형화 될 수 있으나, 이에 제한되는 것은 아니다. The cosmetic composition according to the present invention may be prepared in any formulation conventionally prepared in the technical field to which the present invention pertains. For example, to be formulated into lotions, emulsions, skins, lotions, essences, ampoules, creams, pastes, gels, solutions, suspensions, oils, waxes, packs, powders, foundations, sprays, surfactant-containing cleansing, soaps, etc. However, the present invention is not limited thereto.
더욱 상세하게는, 유연 화장수, 영양 화장수, 수렴 화장수, 영양 크림, 마사지 크림, 밀크 로션, 파우더, 에센스, 아이 크림, 선로션, 선크림, 메이크업 프라이머, 메이크업 베이스, 비비크림, 분말 파운데이션, 유탁액 파운데이션, 클렌징크림, 클렌징폼, 클렌징 워터, 비누, 팩, 스틱상 제품, 밤(Balm) 타입 제품, 스프레이 또는 파우더의 제형으로 제조될 수 있다.More specifically, flexible lotion, nourishing lotion, astringent lotion, nourishing cream, massage cream, milk lotion, powder, essence, eye cream, sun lotion, sun cream, makeup primer, makeup base, BB cream, powder foundation, emulsion foundation , cleansing cream, cleansing foam, cleansing water, soap, pack, stick type product, balm type product, spray or powder formulation.
본 발명에 따른 화장료 조성물이 크림 또는 젤 제형인 경우에는 담체 성분으로 동물성유, 식물성유, 왁스, 파라핀, 전분, 셀룰로오스 유도체, 폴리에틸렌 글리콜, 실리콘, 벤토나이트, 실리카, 탈크 또는 산화아연 등을 더 포함할 수 있다.When the cosmetic composition according to the present invention is a cream or gel formulation, animal oil, vegetable oil, wax, paraffin, starch, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be further included as a carrier component. can
상기 화장료 조성물이 용액 또는 유탁액 제형인 경우에는 용매, 용매화제 또는 유탁화제로, 물, 에탄올, 이소프로판올, 에틸카보네이트, 에틸아세테이트, 벤질알코올, 프로필렌글리콜, 글리세롤 지방족 에스테르, 폴리에틸렌글리콜 또는 소르비탄의 지방산 에스테르 등을 더 포함할 수 있다.When the cosmetic composition is a solution or emulsion formulation, a solvent, solvating agent or emulsifying agent, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, benzyl alcohol, propylene glycol, glycerol aliphatic ester, polyethylene glycol or sorbitan fatty acid It may further include esters and the like.
상기 화장료 조성물이 현탁액 제형인 경우에는 담체 성분으로 물, 에탄올 또는 프로필렌 글리콜과 같은 액상 희석제, 에톡실화 이소스테아릴 알코올, 폴리옥시에틸렌 소르비톨 에스테르 및 폴리옥시에틸렌 소르비탄 에스테르와 같은 현탁제, 미소결정성 셀룰로오스, 알루미늄 메타히드록시드, 벤토나이트, 아가 또는 트라칸트 등을 더 포함할 수 있다.When the cosmetic composition is a suspension formulation, as a carrier component, a liquid diluent such as water, ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be further included.
상기 화장료 조성물이 파우더 또는 스프레이 제형인 경우에는 담체 성분으로 락토스, 탈크, 실리카, 알루미늄 히드록시드, 칼슘 실리케이트 또는 폴리아미드 파우더를 더 포함할 수 있고, 특히 스프레이 제형인 경우에는 추가적으로 클로로플루오로히드로카본, 프로판/부탄 또는 디메틸에테르와 같은 추진체를 더 포함할 수 있다.When the cosmetic composition is in a powder or spray formulation, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be further included as a carrier component, and in particular, in the case of a spray formulation, additional chlorofluorohydrocarbon , may further include a propellant such as propane/butane or dimethyl ether.
상기 화장료 조성물이 계면활성제-함유 클렌징 제형인 경우에는 담체 성분으로 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성유, 리놀린 유도체 또는 에톡실화 글리세롤 지방산 에스테르 등을 더 포함할 수 있다.When the cosmetic composition is a surfactant-containing cleansing formulation, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid amide as carrier components Ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid glycerides, fatty acid diethanolamide, vegetable oil, linoline derivatives or ethoxylated glycerol fatty acid esters may be further included.
본 발명에 따른 화장료 조성물은 단독 또는 중복으로 도포하여 사용하거나, 본 발명 이외의 다른 화장료 조성물과 중복 도포하여 사용할 수 있다. 또한, 본 발명에 따른 화장료 조성물은 통상적인 사용방법에 따라 사용될 수 있으며, 사용자의 피부 상태 또는 취향에 따라 그 사용횟수를 달리할 수 있다.The cosmetic composition according to the present invention may be applied alone or in overlapping use, or may be used by overlapping application with other cosmetic compositions other than the present invention. In addition, the cosmetic composition according to the present invention can be used according to a conventional method of use, and the number of times of use can be varied according to the skin condition or taste of the user.
이하, 본 발명의 이해를 돕기 위하여 실시예를 들어 상세하게 설명하기로 한다. 다만 하기의 실시예는 본 발명의 내용을 예시하는 것일 뿐 본 발명의 범위가 하기 실시예에 한정되는 것은 아니다. 본 발명의 실시예는 당업계에서 평균적인 지식을 가진 자에게 본 발명을 보다 완전하게 설명하기 위해 제공되는 것이다.Hereinafter, examples will be described in detail to help the understanding of the present invention. However, the following examples are merely illustrative of the content of the present invention, and the scope of the present invention is not limited to the following examples. The embodiments of the present invention are provided to more completely explain the present invention to those of ordinary skill in the art.
<실시예 1> 노르데나우수, 인체유래 줄기세포 배양액 추출물 및 병풀 추출물을 포함하는 화장료 조성물 제조<Example 1> Preparation of cosmetic composition comprising Nordenau water, human stem cell culture extract and Centella asiatica extract
독일의 의료용 광천수인 노르데나우수를 준비하고, 인체 지방조직 유래 줄기세포 배양액(Human adipose-derived mesenchymal stem cells-conditioned medium, ADSC-CM) 추출물 및 병풀 추출물을 제조하였다.Nordenau water, a German medical mineral water, was prepared, and human adipose-derived mesenchymal stem cells-conditioned medium (ADSC-CM) extract and Centella asiatica extract were prepared.
지방 흡입술을 통해 얻어진 지방조직으로부터 지방줄기세포를 분리하고, 이를 기질 배지에 현탁시켜 배양 용기에 접종한 후 37℃, CO2 인큐베이터에서 24시간 동안 배양한 뒤 기질 배지를 제거하고 분화 배지를 넣어 3일 동안 배양한 후 지방세포 배지(adipocyte media)를 넣고 지방세포로 분화시켰다. 이 과정에서 얻어진 배양액을 분리 정제하여 본 발명의 지방조직 유래 줄기세포 배양액 추출물로 사용하였다.Adipose stem cells are separated from adipose tissue obtained through liposuction, suspended in a substrate medium, inoculated in a culture vessel, and cultured in an incubator at 37° C., CO 2 for 24 hours, then the substrate medium is removed and a differentiation medium is added 3 After culturing for one day, adipocyte media was added and the cells were differentiated into adipocytes. The culture solution obtained in this process was separated and purified and used as an extract of the adipose tissue-derived stem cell culture solution of the present invention.
병풀 전초를 채집하여 세척 및 건조시킨 후 분쇄하였다. 분쇄된 병풀 100g을 2L의 증류수에 첨가하여 약 95℃에서 3시간 동안 가열하여 열수 추출하였다. 이를 여과한 뒤, 40℃ 이하에서 감압 농축 후, 동결 건조하였다.Centella asiatica was collected, washed, dried, and then pulverized. 100 g of pulverized Centella asiatica was added to 2 L of distilled water and heated at about 95° C. for 3 hours, followed by hot water extraction. After filtration, the resultant was concentrated under reduced pressure at 40° C. or lower, and then freeze-dried.
상기에 따라 준비된 노르데나우수, 인체 지방조직 유래 줄기세포 배양액 추출물, 병풀 추출물을 함유한 화장료 조성물(실시예 1)을 표 1의 성분 및 함량으로 제조하였다.A cosmetic composition (Example 1) containing Nordenau water, human adipose tissue-derived stem cell culture extract, and Centella asiatica extract prepared according to the above was prepared with the components and contents of Table 1.
성분ingredient | 함량 (w/w)%Content (w/w)% | 기능function |
노르데나우수Nordenausu | 30.0000000030.00000000 | 항산화제antioxidant |
인체지방세포 배양액 추출물Human adipocyte culture extract | 20.0000000020.00000000 | 피부재생, 콜라겐합성 등Skin regeneration, collagen synthesis, etc. |
글리세린glycerin | 5.004900005.00490000 | 보습제moisturizer |
메틸프로판다이올methyl propanediol | 3.200000003.20000000 |
용매, 용제, 보습제solvent, solvent, |
1,2-헥산다이올1,2-Hexanediol | 2.074461502.07446150 | 산화방지, 보존제, 보습제 등Antioxidant, preservative, moisturizer, etc. |
나이아신아마이드niacinamide | 2.000000002.00000000 | 미백제whitening agent |
병풀 추출물Centella asiatica extract | 0.023620000.02362000 | 피부재생. 항산화 등skin regeneration. antioxidant, etc. |
알란토인allantoin | 0.100000000.10000000 | 피부컨디셔닝skin conditioning |
아스코빌프로필하이알루네이트Ascorbyl propyl hyalurate | 0.000000600.00000060 | 보습제, 항산화 등Moisturizer, antioxidant, etc. |
아세틸헥사펩타이드-8Acetylhexapeptide-8 | 0.000010000.00001000 | 항노화anti aging |
정제수Purified water | 잔량remaining amount | 용제solvent |
<실험예 1> 세포 증식 효과 확인<Experimental Example 1> Confirmation of cell proliferation effect
ATCC로부터 구입한 인간 진피 섬유아세포인 HDF(human dermal fibroblast) 세포를 96 well plate에 5×103 cell/well로 분주하고, 37℃, 5% CO2에서 0.5% FBS(fetal bovine serum)가 첨가된 DMEM(Invitrogen-Gibco-BRL, Grand Island, NY) 배지로 24시간 배양하였다. 최종 농도가 1%(v/v)가 되도록 배양 배지로 희석한 실시예 1과 비교예로 내피세포성장인자(epidermal growth factor, EGF) 시료 50μg/ml을 첨가한 후 24시간 동안 배양하였다. 10㎕의 CCK-8(Cell counting kit-8, Dojindo, Gaithersburg, MD, USA) 용액을 각 well에 첨가하고 2시간 동안 배양하였다. 이를 마이크로플레이트 리더기를 이용하여 450 ㎚에서 흡광도를 측정하였다.Human dermal fibroblast (HDF) cells, which are human dermal fibroblasts purchased from ATCC, were aliquoted at 5×10 3 cells/well in a 96 well plate, and 0.5% FBS (fetal bovine serum) was added at 37° C., 5% CO 2 . It was cultured for 24 hours in DMEM (Invitrogen-Gibco-BRL, Grand Island, NY) medium. In Example 1 and Comparative Example diluted with a culture medium to a final concentration of 1% (v/v), 50 μg/ml of an epidermal growth factor (EGF) sample was added and cultured for 24 hours. 10 μl of CCK-8 (Cell counting kit-8, Dojindo, Gaithersburg, MD, USA) solution was added to each well and incubated for 2 hours. The absorbance was measured at 450 nm using a microplate reader.
그 결과, 도 1과 같이, 실시예 1의 조성물이 성장인자 EGF에 비해 더 향상된 세포 증식 효과를 나타내었다.As a result, as shown in FIG. 1, the composition of Example 1 exhibited a more improved cell proliferation effect than the growth factor EGF.
<실험예 2> 콜라겐 합성량 비교<Experimental Example 2> Comparison of collagen synthesis amount
타사의 줄기세포 배양액이 포함된 화장료 조성물과 본 발명에 따른 실시예 1의 조성물의 콜라겐 합성 촉진 효과를 확인하기 위해, Procollagen Type I C-Peptide Enzyme Immuno Assay 실험을 수행하였다.In order to confirm the collagen synthesis promoting effect of the cosmetic composition containing the stem cell culture medium of another company and the composition of Example 1 according to the present invention, a Procollagen Type I C-Peptide Enzyme Immuno Assay experiment was performed.
HDF 세포를 96 well plate에 5×103 cell/well로 분주하고, DMEM 배지에 37℃의 조건에서 24시간 배양한 후, 타사의 화장료 조성물과 본 발명에 따른 실시예 1을 50μg/ml 처리한 다음 48시간 동안 무혈청 배지에서 추가로 배양하였다. 배양 후, 각 웰의 상층액을 모아 프로콜라겐(procollagen) 타입 I C-펩타이드 (PICP) 양을 키트 (Takara, JAPAN)를 이용하여 측정함으로써 콜라겐 합성량을 측정하였다.HDF cells were aliquoted in a 96-well plate at 5×10 3 cells/well, cultured in DMEM medium at 37° C. for 24 hours, and then treated with a cosmetic composition of another company and Example 1 according to the present invention at 50 μg/ml. Further incubation in serum-free medium for the next 48 hours. After incubation, the amount of collagen synthesis was measured by collecting the supernatant of each well and measuring the amount of procollagen type I C-peptide (PICP) using a kit (Takara, JAPAN).
그 결과, 도 2와 같이, 실시예 1이 타사의 줄기세포배양액보다 더 높은 콜라겐 합성량을 가짐을 확인할 수 있었다.As a result, as shown in FIG. 2 , it was confirmed that Example 1 had a higher collagen synthesis amount than that of other stem cell cultures.
<실험예 3> 멜라닌 함유량 및 티로시나제 활성 비교<Experimental Example 3> Comparison of melanin content and tyrosinase activity
멜라닌 함량 측정은 24 well plate에 2×104 cells/well로 ATCC로부터 분양받은 B16F10 melanoma cell을 분주하고 37℃, 5% CO2에서 18시간 배양 후 배양액을 제거하였다. 멜라닌의 생합성을 유도하기 위하여 0.2 ppm α-MSH(α-melanocyte stimulating hormone, Sigma-Aldrich)를 포함하는 배양액으로 교환한 후, 시료를 농도별로 각각 첨가하여 24시간 동안 배양하였다. 이후 배지를 제거하고 PBS를 바닥 면이 골고루 펴지게 일정량을 분주한 후 바로 세척하여, trypsin-EDTA를 처리하여 세포를 회수한 뒤, 세포내의 멜라닌(melanin) 함량을 ELISA를 이용하여 405 nm에서 흡광도를 측정하였다.Melanin content was measured by dispensing B16F10 melanoma cells distributed from ATCC at 2×10 4 cells/well in a 24-well plate, and cultured at 37° C., 5% CO 2 for 18 hours, and then the culture medium was removed. In order to induce the biosynthesis of melanin, the culture medium containing 0.2 ppm α-MSH (α-melanocyte stimulating hormone, Sigma-Aldrich) was exchanged, and each sample was added by concentration and cultured for 24 hours. After removing the medium and dispensing a certain amount of PBS so that the bottom surface is evenly spread, the cells are recovered by treatment with trypsin-EDTA, and the melanin content in the cells is measured by ELISA for absorbance at 405 nm. was measured.
그 결과, 도 3 및 4와 같이 실시예 1을 처리한 경우, α-MSH 단독 처리한 경우에 비하여 농도가 증가할수록 멜라닌 생성 및 티로시나제 효소 활성이 유의적으로 억제되는 것으로 나타났다.As a result, as shown in FIGS. 3 and 4, when Example 1 was treated, melanin production and tyrosinase enzyme activity were significantly inhibited as the concentration increased compared to the case of α-MSH alone treatment.
또한, 실시예 1의 농도가 50μg/ml일 경우, 기존의 티로시나제 억제제(tyrosinase inhibitor)로 알려진 양성 대조군 알부틴(arbutin)보다 멜라닌 및 티로시나제 효소 활성의 억제 효과가 뛰어난 것으로 보여진다.In addition, when the concentration of Example 1 is 50 μg / ml, it is shown that the inhibitory effect of melanin and tyrosinase enzyme activity is superior to that of arbutin, a positive control known as a conventional tyrosinase inhibitor.
하기에 본 발명에 따른 노르데나우수, 인체 지방조직 유래 줄기세포 배양액 추출물, 병풀 추출물을 포함하는 화장료 조성물의 제제예를 설명하나, 본 발명은 이를 한정하고자 함이 아닌 단지 구체적으로 설명하고자 함이다.Hereinafter, a formulation example of a cosmetic composition comprising Nordenau water, a human adipose tissue-derived stem cell culture extract, and Centella asiatica extract according to the present invention will be described, but the present invention is not intended to limit it, but to describe it in detail.
<제조예 1> 노르데나우수, 인체 지방조직 유래 줄기세포 배양액 추출물, 병풀 추출물을 함유한 기능성 앰플 제조<Preparation Example 1> Preparation of functional ampoule containing Nordenau water, human adipose tissue-derived stem cell culture medium extract, and Centella asiatica extract
하기 표 2는 본 발명의 일 실시예에 따른 노르데나우수, 인체 지방조직 유래 줄기세포 배양액 추출물, 병풀 추출물을 유효성분으로 포함하는 기능성 앰플의 성분 및 함량으로, 진피층까지 침투되어 피부 흡수력을 향상시키는 나노사이즈 입자 제조방법을 활용하여 기능성 앰플을 제조하였다.Table 2 below shows the ingredients and contents of functional ampoules containing Nordenau water, human adipose tissue-derived stem cell culture extract, and Centella asiatica extract as active ingredients according to an embodiment of the present invention. A functional ampoule was prepared using the nano-size particle manufacturing method.
성분ingredient | 함량 (w/w)%Content (w/w)% |
노르데나우수Nordenausu | 30.0030.00 |
인체지방세포배양액추출물Human fat cell culture solution extract | 20.0020.00 |
글리세린glycerin | 5.005.00 |
메틸프로판다이올methyl propanediol | 3.203.20 |
1,2-헥산다이올1,2-Hexanediol | 2.072.07 |
부틸렌글라이콜Butylene Glycol | 0.700.70 |
세라마이드엔피Ceramide NP | 0.500.50 |
베타인betaine | 0.300.30 |
소듐하이알루로네이트Sodium Hyaluronate | 0.050.05 |
병풀 추출물Centella asiatica extract | 0.080.08 |
마치현 추출물Machiba extract | 0.060.06 |
코코넛야자오일coconut palm oil | 0.080.08 |
해바라기씨오일sunflower seed oil | 0.080.08 |
글리세릴아크릴레이트/아크릴릭애씨드코폴리머Glyceryl Acrylate/Acrylic Acid Copolymer | 0.010.01 |
카프릴릭/카프릭트라이글리세라이드Caprylic/Capric Triglycerides | 0.050.05 |
알란토인allantoin | 0.100.10 |
옥틸도데세스-16Octyldodeces-16 | 0.150.15 |
소듐코코피지-다이모늄클로라이드포스페이트Sodium Coco-Sebum - Dimonium Chloride Phosphate | 0.100.10 |
다이소듐이디티에이Disodium EDIT | 0.020.02 |
아데노신adenosine | 0.040.04 |
트로메타민tromethamine | 0.040.04 |
정제수Purified water | 잔량remaining amount |
<실험예 4> 관능 평가 <Experimental Example 4> Sensory evaluation
제조예 1에서 기능성 앰플에 대한 사용감을 평가하기 위하여, 흡수력, 보습력, 피부 안정감(리프팅 느낌 등), 향미 및 전체적인 만족도에 대한 관능 테스트를 진행하였다. 성인 여성 20인(44~61세)을 대상으로 상기 제조예 1의 기능성 앰플과 자사의 기존 앰플에 대한 흡수력, 보습력, 피부안정감, 향미 및 전체적 만족도를 1 내지 10의 지수로 평가하도록 하였고, 그 결과를 하기의 표 3에 나타내었다.In order to evaluate the feeling of use of the functional ampoule in Preparation Example 1, sensory tests for absorption, moisturizing power, skin stability (lifting feeling, etc.), flavor, and overall satisfaction were performed. For 20 adult women (44 to 61 years old), the functional ampoule of Preparation Example 1 and its existing ampoule were evaluated for absorption, moisturizing power, skin stability, flavor and overall satisfaction on a scale of 1 to 10, and the The results are shown in Table 3 below.
하기의 표 3에서 각 지수는 그 수치가 높을수록 효과가 우수한 것이다.In Table 3 below, each index has an excellent effect as its numerical value is higher.
기존 자사 앰플Existing own ampoules | 제조예 1Preparation Example 1 | |
흡수력absorptivity | 6.26.2 | 8.48.4 |
보습력moisturizing power | 6.06.0 | 9.19.1 |
피부 안정감(리프팅)Skin stability (lifting) | 6.16.1 | 8.88.8 |
향미flavor | 5.55.5 | 8.38.3 |
전체적 만족도overall satisfaction | 66 | 8.78.7 |
상기 표 3을 참조하면, 전반적으로 기존 자사의 앰플보다 본 발명에 따른 제조예 1의 기능성 앰플이 긍정적으로 평가됨을 확인할 수 있다.Referring to Table 3, it can be seen that the functional ampoule of Preparation Example 1 according to the present invention is evaluated more positively than the existing ampoules.
또한, 상기 성인 여성을 대상으로 상기 제조예 1의 기능성 앰플 사용 4주차 및 8주차의 미백 개선 효과를 수치화하여 확인한 결과, 도 5와 같이 눈으로 확인 가능한 개선 효과를 나타내었다.In addition, as a result of numerically confirming the whitening improvement effect at the 4th week and the 8th week of using the functional ampoule of Preparation Example 1 for the adult female, an improvement effect that can be confirmed visually as shown in FIG. 5 was shown.
이상으로 본 발명 내용의 특정한 부분을 상세히 기술하였는 바, 당업계의 통상의 지식을 가진 자에게 있어서, 이러한 구체적 기술은 단지 바람직한 실시양태일 뿐이며, 이에 의해 본 발명의 범위가 제한되는 것이 아닌 점은 명백하다. 즉, 본 발명의 실질적인 범위는 첨부된 청구항들과 그것들의 등가물에 의하여 정의된다.As described above in detail a specific part of the content of the present invention, for those of ordinary skill in the art, it is clear that this specific description is only a preferred embodiment, and the scope of the present invention is not limited thereby. Do. That is, the substantial scope of the present invention is defined by the appended claims and their equivalents.
Claims (11)
- 노르데나우수, 인체유래 줄기세포 배양액 추출물, 병풀 추출물 및 정제수를 포함하는 기능성 화장료 조성물.Functional cosmetic composition comprising Nordenau water, human stem cell culture extract, Centella asiatica extract and purified water.
- 제 1 항에 있어서, The method of claim 1,상기 조성물은,The composition is노르데나우수 20 내지 40 중량%, 인체유래 줄기세포 배양액 추출물 15 내지 30 중량%, 병풀 추출물 0.005 내지 0.1 중량% 및 잔량의 정제수를 포함하는 기능성 화장료 조성물.Nordenau water 20 to 40% by weight, human stem cell culture extract 15 to 30% by weight, Centella asiatica extract 0.005 to 0.1% by weight Functional cosmetic composition comprising the remaining amount of purified water.
- 제 1 항에 있어서, The method of claim 1,상기 노르데나우수는,The Nordenau number is독일 노르데나우 토메스 동굴에서 나는 미네랄 워터인 것을 특징으로 하는 기능성 화장료 조성물.A functional cosmetic composition, characterized in that it is mineral water from Tomes Cave in Nordenau, Germany.
- 제 1 항에 있어서, The method of claim 1,상기 인체유래 줄기세포 배양액 추출물은,The human-derived stem cell culture solution extract,인체유래 지방줄기세포를 배양하여 얻은 배양액 및 상기 배양한 지방줄기세포를 파쇄하여 얻은 추출물인 것을 특징으로 하는 기능성 화장료 조성물.A functional cosmetic composition comprising a culture solution obtained by culturing human adipose stem cells and an extract obtained by crushing the cultured adipose stem cells.
- 제 1 항에 있어서, The method of claim 1,상기 병풀 추출물은,The Centella asiatica extract is병풀의 열수 추출물인 것을 특징으로 하는 기능성 화장료 조성물.A functional cosmetic composition, characterized in that it is a hot water extract of Centella asiatica.
- 제 1 항에 있어서, The method of claim 1,상기 조성물은,The composition is평균직경 0.1 내지 100 nm 나노입자의 형태로 피부에 제공되는 것을 특징으로 하는 기능성 화장료 조성물. A functional cosmetic composition, characterized in that it is provided to the skin in the form of nanoparticles with an average diameter of 0.1 to 100 nm.
- 제 1 항에 있어서, The method of claim 1,상기 조성물은,The composition is주름개선 효과를 갖는 것을 특징으로 하는 기능성 화장료 조성물.A functional cosmetic composition, characterized in that it has a wrinkle-improving effect.
- 제 1 항에 있어서, The method of claim 1,상기 조성물은,The composition is미백 효과를 갖는 것을 특징으로 하는 기능성 화장료 조성물.A functional cosmetic composition, characterized in that it has a whitening effect.
- 제 1 항에 있어서, The method of claim 1,상기 조성물은,The composition is알란토인, 히알루론산, 나이아신아마이드, 아세틸헥사펩타이드-8, 및 마치현 추출물로 이루어진 군에서 선택된 하나 이상의 성분을 더 포함하는 것을 특징으로 하는 기능성 화장료 조성물.Functional cosmetic composition, characterized in that it further comprises one or more ingredients selected from the group consisting of allantoin, hyaluronic acid, niacinamide, acetyl hexapeptide-8, and Machihyun extract.
- 제 1 항에 있어서, The method of claim 1,상기 조성물은,The composition is토코페롤, 소듐설파이트, 소듐하이드로젠설파이트, 소듐메타바이설파이트, 포타슘설파이트, 포타슘하이드로젠설파이트, 포타슘메타바이설파이트, 부틸레이티드하이드록시톨루엔, 부틸하이드록시아니솔, 아스코르브산 및 아스코르빌팔미테이트로 이루어진 군으로부터 선택된 하나 이상의 산화방지제를 더 포함하는 것을 특징으로 하는 기능성 화장료 조성물.Tocopherol, sodium sulfite, sodium hydrogensulfite, sodium metabisulfite, potassium sulfite, potassium hydrogensulfite, potassium metabisulfite, butylated hydroxytoluene, butylhydroxyanisole, ascorbic acid and Functional cosmetic composition, characterized in that it further comprises one or more antioxidants selected from the group consisting of ascorbyl palmitate.
- 제 1 항에 있어서, The method of claim 1,상기 조성물은,The composition is스킨, 로션, 에센스, 앰플, 크림, 젤 또는 비누로 제조되는 것을 특징으로 하는 기능성 화장료 조성물.A functional cosmetic composition, characterized in that it is prepared in skin, lotion, essence, ampoule, cream, gel or soap.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2020-0117410 | 2020-09-14 | ||
KR1020200117410A KR20220035553A (en) | 2020-09-14 | 2020-09-14 | Functional cosmetic composition using nordenau water |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022055034A1 true WO2022055034A1 (en) | 2022-03-17 |
Family
ID=80630316
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2020/017019 WO2022055034A1 (en) | 2020-09-14 | 2020-11-27 | Functional cosmetic composition using nordenau water |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20220035553A (en) |
WO (1) | WO2022055034A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110119062A (en) * | 2010-04-26 | 2011-11-02 | (주)프로스테믹스 | Enriched media of human adipose tissue-derived stem cells having skin regeneration or antiwrinkle effect and uses thereof |
KR20150142287A (en) * | 2014-06-11 | 2015-12-22 | (유)스템메디케어 | Culture media compostion for promoting stem cell proliferation comprising plant extracts |
KR20160015571A (en) * | 2014-07-31 | 2016-02-15 | 주식회사 휴메딕스 | Cosmetic Composition containing Human Adipocyte Conditioned Media Extract and Hyaluronic acid |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20060034737A (en) | 2004-10-19 | 2006-04-25 | (주)스파쿠아 | Cosmetic composition comprising artificially prepared water containing mineral components |
-
2020
- 2020-09-14 KR KR1020200117410A patent/KR20220035553A/en not_active Application Discontinuation
- 2020-11-27 WO PCT/KR2020/017019 patent/WO2022055034A1/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20110119062A (en) * | 2010-04-26 | 2011-11-02 | (주)프로스테믹스 | Enriched media of human adipose tissue-derived stem cells having skin regeneration or antiwrinkle effect and uses thereof |
KR20150142287A (en) * | 2014-06-11 | 2015-12-22 | (유)스템메디케어 | Culture media compostion for promoting stem cell proliferation comprising plant extracts |
KR20160015571A (en) * | 2014-07-31 | 2016-02-15 | 주식회사 휴메딕스 | Cosmetic Composition containing Human Adipocyte Conditioned Media Extract and Hyaluronic acid |
Non-Patent Citations (2)
Title |
---|
SHALLOT: "Moisture Essence Erztin Rejuvenation Flegue Gel Review", BLOG NAVER, NAVER, KOREA, 23 July 2018 (2018-07-23), Korea, pages 1 - 15, XP055911446, Retrieved from the Internet <URL:https://blog.naver.com/blueveryday7/221324541099> [retrieved on 20220411] * |
VIEW STAR: "Skin care with Celltage stem cell cosmetics and beauty devices!", BLOG NAVER, NAVER, 11 September 2020 (2020-09-11), pages 1 - 33, XP055911441, Retrieved from the Internet <URL:https://m.blog.naver.com/m_l_93/222086711844> [retrieved on 20220411] * |
Also Published As
Publication number | Publication date |
---|---|
KR20220035553A (en) | 2022-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2013027984A2 (en) | Cosmetic composition containing green tea component | |
US8101214B2 (en) | Composition for skin external application containing complex of herbal extracts | |
KR101207557B1 (en) | Cosmetic Composition Comprising the Extract of Liriodendron tulipifera as Active Ingredient | |
KR20130035325A (en) | External composition for skin containing saponin derived from the root of camellia sinensis | |
KR101885195B1 (en) | Cosmetic Composition with Fermentative Extract of Osmanthus fragrans | |
KR102251854B1 (en) | Cosmetic composition for skin moisturizing and anti-wrinkle comprising Chamaecyparis obtusa leaf mixed extract as effective component | |
KR101860109B1 (en) | Skin external composition containing floral ginsenoside | |
KR102373899B1 (en) | Multifunctional cosmetic composition containing complex natural extracts effective for skin wrinkle improvement, whitening, cell regeneration, and wound healing as an active ingredient | |
KR102286679B1 (en) | External composition for skin containing an enzyme-treated saponin fraction derived from the root of Camellia sinensis | |
KR20150078868A (en) | Cosmetic composition containing ginsenoside Rd, Rb2 and Bambusae Caulis in Taeniam extracts | |
KR101860352B1 (en) | A cosmetic composition for treating demodex infestations comprising extract of artemisia apiaceae | |
KR102473093B1 (en) | Cosmetic composition for improving skin condition comprising hemp seed oil, plant callus culture filtrate and peptides as active ingredient | |
KR102154927B1 (en) | A cosmetic composition for anti-aging, anti-oxidant, skin regeneration comprising chlorogenic acid, ferulic acid, resveratrol, and Streptococcus thermophilus fermented extract | |
WO2022055034A1 (en) | Functional cosmetic composition using nordenau water | |
KR100903654B1 (en) | Cosmetic compositions comprising Prunella Vulgaris extract and Adenosine | |
KR101854766B1 (en) | Skin whitening complex containing trihydroxyisoflavone and glycyrrhiza uralensis extracts | |
KR20190021114A (en) | Composition for anti-inflammation, inhibiting secretion of sebum, or treating acne on the skin comprising plant extract | |
KR20110122448A (en) | Cosmetic composition comprising the extract of filipendula formosa as active ingredient | |
KR102335682B1 (en) | Cosmetic Composition For Moisturizing Skin Comprising Fermentative Extract of Equisetum giganteum | |
KR101719723B1 (en) | Cosmetic composition comprising the extract of Ensete lasiocarpum as active ingredient | |
KR20200073584A (en) | Cosmetic composition for alleviating acne containing effective ingredient of rhododendron brachycarpum and perillafrutescens leaffor | |
KR20190048931A (en) | Cosmetic composition comprising extract of saliva miltiorrhiza | |
KR101557422B1 (en) | Cleansing composition and cosmetic composition with the extract of Styrax japonica | |
KR20030017300A (en) | Cosmetic compositions containing extracts of Prunus armeniaca L, Vitis vinifera L. and Perilla frutescens var. japonica Hara | |
KR102308302B1 (en) | Cosmetic Compositions for Anti-aging Comprising Fermented Product of Astragalus membranaceus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 20953436 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 112(1) EPC (EPO FORM 1205A DATED 07/08/2023) |